IBIO Stock: iBio, Inc. Stock Price, Analysis & Insights

Get live IBIO stock price $1.71, comprehensive iBio, Inc. stock analysis, charts, news, and expert forecast. Real-time IBIO stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

1.71

0.59%Today

IBIO • iBio, Inc. • NASDAQ Capital Market • Healthcare

Market Cap

27.00M

Volume

69.13K

52W High

3.82

52W Low

0.56

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two distinct segments: Biopharmaceuticals and Bioproce...

Contact Information

Website: https://www.ibioinc.com
Address: 8800 HSC Parkway
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Higher growth potential with elevated volatility (Beta: 1.27)

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for iBio, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for iBio, Inc.
⚠Investors should consider how iBio, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

27.00M

P/E Ratio (TTM)

-3.05

Beta

1.27

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare IBIO with peer companies:

AN2 Therapeutics, Inc. (ANTX)

Price: $4.21
Market cap: 115.36M

Boundless Bio, Inc. (BOLD)

Price: $1.39
Market cap: 31.23M

Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Price: $3.99
Market cap: 11.43M

Intensity Therapeutics, Inc. (INTS)

Price: $3.67
Market cap: 6.93M

Iterum Therapeutics plc (ITRM)

Price: $0.03
Market cap: 1.60M

Klotho Neurosciences, Inc. (KLTO)

Price: $0.38
Market cap: 20.08M

Pluri Inc. (PLUR)

Price: $2.27
Market cap: 20.41M

Plus Therapeutics, Inc. (PSTV)

Price: $5.61
Market cap: 13.57M

Rallybio Corporation (RLYB)

Price: $16.32
Market cap: 86.47M

Exicure, Inc. (XCUR)

Price: $2.80
Market cap: 17.85M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.